SNS Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08M | Buy |
+36,127
| New | +$2.07M | 0.04% | 217 |
|
|
2024
Q4 | – | Sell |
-4,077
| Closed | -$211K | – | 191 |
|
|
2024
Q3 | $211K | Buy |
+4,077
| New | +$191K | 0.02% | 185 |
|
|
2024
Q2 | – | Sell |
-5,658
| Closed | -$307K | – | 190 |
|
|
2024
Q1 | $307K | Buy |
5,658
+40
| +0.7% | +$2.04K | 0.03% | 148 |
|
|
2023
Q4 | $288K | Buy |
5,618
+187
| +3% | +$9.82K | 0.03% | 147 |
|
|
2023
Q3 | $315K | Sell |
5,431
-116
| -2% | -$7.11K | 0.04% | 138 |
|
|
2023
Q2 | $355K | Sell |
5,547
-278
| -5% | -$18.6K | 0.05% | 128 |
|
|
2023
Q1 | $404K | Sell |
5,825
-146
| -2% | -$10.3K | 0.05% | 124 |
|
|
2022
Q4 | $430K | Buy |
5,971
+264
| +5% | +$19.9K | 0.06% | 124 |
|
|
2022
Q3 | $406K | Sell |
5,707
-11
| -0.2% | -$798 | 0.06% | 123 |
|
|
2022
Q2 | $444K | Sell |
5,718
-329
| -5% | -$25.1K | 0.06% | 118 |
|
|
2022
Q1 | $441K | Sell |
6,047
-329
| -5% | -$22.1K | 0.05% | 136 |
|
|
2021
Q4 | $397K | Sell |
6,376
-195
| -3% | -$11.4K | 0.04% | 154 |
|
|
2021
Q3 | $389K | Hold |
6,571
| – | – | 0.05% | 144 |
|
|
2021
Q2 | $439K | Sell |
6,571
-254
| -4% | -$16.6K | 0.06% | 135 |
|
|
2021
Q1 | $431K | Hold |
6,825
| – | – | 0.06% | 127 |
|
|
2020
Q4 | $423K | Buy |
6,825
+1,508
| +28% | +$92.7K | 0.06% | 129 |
|
|
2020
Q3 | $321K | Buy |
5,317
+522
| +11% | +$31.4K | 0.05% | 147 |
|
|
2020
Q2 | $282K | Sell |
4,795
-153
| -3% | -$9.15K | 0.05% | 146 |
|
|
2020
Q1 | $276K | Buy |
4,948
+240
| +5% | +$14.7K | 0.05% | 153 |
|
|
2019
Q4 | $302K | Buy |
+4,708
| New | +$270K | 0.05% | 165 |
|
|
2019
Q1 | – | Sell |
-4,378
| Closed | -$228K | – | 194 |
|
|
2018
Q4 | $228K | Hold |
4,378
| – | – | 0.06% | 160 |
|
|
2018
Q3 | $272K | Sell |
4,378
-63
| -1% | -$3.74K | 0.07% | 144 |
|
|
2018
Q2 | $246K | Sell |
4,441
-50
| -1% | -$2.7K | 0.06% | 145 |
|
|
2018
Q1 | $284K | Sell |
4,491
-912
| -17% | -$58.7K | 0.08% | 127 |
|
|
2017
Q4 | $331K | Buy |
5,403
+291
| +6% | +$18.2K | 0.08% | 128 |
|
|
2017
Q3 | $326K | Sell |
5,112
-157
| -3% | -$9.17K | 0.08% | 125 |
|
|
2017
Q2 | $293K | Sell |
5,269
-366
| -6% | -$19.9K | 0.08% | 130 |
|
|
2017
Q1 | $306K | Sell |
5,635
-5,788
| -51% | -$317K | 0.08% | 136 |
|
|
2016
Q4 | $668K | Buy |
11,423
+4,852
| +74% | +$265K | 0.2% | 88 |
|
|
2016
Q3 | $354K | Buy |
6,571
+600
| +10% | +$38.5K | 0.1% | 92 |
|
|
2016
Q2 | $439K | Buy |
5,971
+467
| +8% | +$33K | 0.11% | 91 |
|
|
2016
Q1 | $352K | Sell |
5,504
-50
| -0.9% | -$3.15K | 0.09% | 86 |
|
|
2015
Q4 | $382K | Sell |
5,554
-250
| -4% | -$16.5K | 0.09% | 87 |
|
|
2015
Q3 | $344K | Sell |
5,804
-575
| -9% | -$36.5K | 0.09% | 90 |
|
|
2015
Q2 | $424K | Sell |
6,379
-59,677
| -90% | -$3.93M | 0.13% | 83 |
|
|
2015
Q1 | $4.26M | Buy |
66,056
+5,390
| +9% | +$337K | 1.55% | 14 |
|
|
2014
Q4 | $3.58M | Buy |
60,666
+3,327
| +6% | +$188K | 1.42% | 15 |
|
|
2014
Q3 | $2.94M | Buy |
57,339
+11,840
| +26% | +$591K | 0.96% | 17 |
|
|
2014
Q2 | $2.21M | Buy |
45,499
+37,211
| +449% | +$1.83M | 0.89% | 21 |
|
|
2014
Q1 | $431K | Sell |
8,288
-2,138
| -21% | -$114K | 0.19% | 58 |
|
|
2013
Q4 | $444K | Buy |
+10,426
| New | +$531K | 0.2% | 81 |
|
Other funds holding BMY
SNS Financial Group's BMY Position: Q2 2026 in Review
SNS Financial Group opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 36,127 shares worth $2.08M. The stake represents 0.04% of the portfolio and ranks #217 among its holdings. This is a return to the name: SNS Financial Group previously reported a position in BMY as recently as Q3 2024.
SNS Financial Group first reported a position in BMY in Q4 2013 and has held it in 41 quarters since. The position peaked at $4.26M in Q1 2015. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- SNS Financial Group held 36,127 shares of Bristol-Myers Squibb worth $2.08M as of Q2 2026.
- Bristol-Myers Squibb was a new SNS Financial Group position in Q2 2026.
- Bristol-Myers Squibb made up 0.04% of SNS Financial Group's portfolio in Q2 2026, its #217 holding.
- SNS Financial Group first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 41 quarters since.
- SNS Financial Group's Bristol-Myers Squibb position peaked at $4.26M in Q1 2015.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.